Galectin Therapeutics GALT

$ 2.74 -2.66%

Quarterly report 2024-Q3
added 11-14-2024

Galectin Therapeutics Balance Sheet 2011-2024 | GALT

Annual Balance Sheet Galectin Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-25.6 M	-18.5 M	-	-27.1 M	-47.4 M	-8.25 M	-3.05 M	-15.4 M	-25.8 M	-29.1 M	-10.5 M	-9.36 M	-6.4 M
Long Term Debt	20 K	66 K	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	46 K	40 K	8 K	44 K	39 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	52 K	-	-	-	-	-	-	6 K	6.52 M
Total Current Liabilities	15.7 M	13 M	9.03 M	5.4 M	2.82 M	2.11 M	2.97 M	3.78 M	1.36 M	1.7 M	2.49 M	1.64 M	2.22 M
Total Liabilities	88.4 M	53.5 M	39.2 M	5.41 M	2.87 M	2.11 M	2.97 M	3.78 M	1.36 M	1.7 M	2.49 M	1.64 M	8.74 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	200 K
Retained Earnings	-354 M	-310 M	-271 M	-	-216 M	-196 M	-181 M	-164 M	-140 M	-119 M	-102 M	-80 M	-69.1 M
Total Assets	28.2 M	21.3 M	41.8 M	29.6 M	48.5 M	9.01 M	4.16 M	15.8 M	26.4 M	29.7 M	10.7 M	9.56 M	6.61 M
Cash and Cash Equivalents	25.7 M	18.6 M	39.6 M	27.1 M	47.5 M	8.25 M	3.05 M	15.4 M	25.8 M	29.1 M	10.5 M	9.36 M	6.4 M
Book Value	-60.2 M	-32.2 M	2.62 M	24.2 M	45.6 M	6.9 M	1.19 M	12 M	25 M	28 M	8.23 M	7.92 M	-2.12 M
Total Shareholders Equity	-62 M	-33.9 M	893 K	22.5 M	43.9 M	5.18 M	-530 K	10.3 M	18 M	21.2 M	1.48 M	1.16 M	-2.12 M

All numbers in USD currency

Quarterly Balance Sheet Galectin Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	7 K	-	32 K	43 K	55 K	-	77 K	87 K	97 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	121 M	110 M	97 M	88.4 M	73 M	71.2 M	62.9 M	53.5 M	40.2 M	41.1 M	39.8 M	39.2 M	28.8 M	16.3 M	4.66 M	5.41 M	5.41 M	5.41 M	5.41 M	2.87 M	2.87 M	2.87 M	2.87 M	2.11 M	2.11 M	2.11 M	2.11 M	2.97 M	2.97 M	2.97 M	2.97 M	3.78 M	3.78 M	3.78 M	3.78 M	1.36 M	1.36 M	1.36 M	1.36 M	1.7 M	1.7 M	1.7 M	1.7 M	2.49 M	2.49 M	2.49 M	2.49 M	1.64 M	1.64 M	1.64 M	1.64 M	2.22 M	2.22 M	2.22 M	2.22 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200 K	200 K	200 K	200 K	200 K	200 K
Retained Earnings	-390 M	-378 M	-366 M	-354 M	-344 M	-330 M	-321 M	-310 M	-299 M	-290 M	-281 M	-271 M	-263 M	-255 M	-246 M	-240 M	-240 M	-240 M	-240 M	-216 M	-216 M	-216 M	-216 M	-196 M	-196 M	-196 M	-196 M	-181 M	-181 M	-181 M	-181 M	-164 M	-164 M	-164 M	-164 M	-140 M	-140 M	-140 M	-140 M	-119 M	-119 M	-119 M	-119 M	-102 M	-102 M	-102 M	-	-	-	-	-	-	-	-	-
Total Assets	29 M	27.7 M	25.9 M	28.2 M	22.2 M	20.1 M	20.2 M	21.3 M	17.9 M	25.9 M	33.6 M	41.8 M	38 M	33.4 M	22.9 M	29.6 M	29.6 M	29.6 M	29.6 M	48.5 M	48.5 M	48.5 M	48.5 M	9.01 M	9.01 M	9.01 M	9.01 M	4.16 M	4.16 M	4.16 M	4.16 M	15.8 M	15.8 M	15.8 M	15.8 M	26.4 M	26.4 M	26.4 M	26.4 M	29.7 M	29.7 M	29.7 M	29.7 M	10.7 M	10.7 M	10.7 M	10.7 M	9.56 M	9.56 M	9.56 M	9.56 M	6.61 M	6.61 M	6.61 M	6.61 M
Cash and Cash Equivalents	27.1 M	25.6 M	23.6 M	25.7 M	20.4 M	18 M	18 M	18.6 M	15.8 M	24.2 M	31.6 M	39.6 M	36.6 M	31.6 M	20.8 M	27.1 M	27.1 M	27.1 M	27.1 M	47.5 M	47.5 M	47.5 M	47.5 M	8.25 M	8.25 M	8.25 M	8.25 M	3.05 M	3.05 M	3.05 M	3.05 M	15.4 M	15.4 M	15.4 M	15.4 M	25.8 M	25.8 M	25.8 M	25.8 M	29.1 M	29.1 M	29.1 M	29.1 M	10.5 M	10.5 M	10.5 M	10.5 M	9.36 M	9.36 M	9.36 M	9.36 M	6.4 M	6.4 M	6.4 M	6.4 M
Book Value	-92.5 M	-82.1 M	-71.1 M	-60.2 M	-50.9 M	-51.1 M	-42.6 M	-32.2 M	-22.3 M	-15.2 M	-6.19 M	2.62 M	9.25 M	17.1 M	18.2 M	24.2 M	24.2 M	24.2 M	24.2 M	45.6 M	45.6 M	45.6 M	45.6 M	6.9 M	6.9 M	6.9 M	6.9 M	1.19 M	1.19 M	1.19 M	1.19 M	12 M	12 M	12 M	12 M	25 M	25 M	25 M	25 M	28 M	28 M	28 M	28 M	8.23 M	8.23 M	8.23 M	8.23 M	7.92 M	7.92 M	7.92 M	7.92 M	4.4 M	4.4 M	4.4 M	4.4 M
Total Shareholders Equity	-94.2 M	-83.9 M	-72.8 M	-62 M	-52.6 M	-52.8 M	-44.4 M	-33.9 M	-24.1 M	-16.9 M	-7.92 M	893 K	7.53 M	15.4 M	16.5 M	22.5 M	22.5 M	22.5 M	22.5 M	43.9 M	43.9 M	43.9 M	43.9 M	5.18 M	5.18 M	5.18 M	5.18 M	-530 K	-530 K	-530 K	-530 K	10.3 M	10.3 M	10.3 M	10.3 M	18 M	18 M	18 M	18 M	21.2 M	21.2 M	21.2 M	21.2 M	1.48 M	1.48 M	1.48 M	1.48 M	1.16 M	1.16 M	1.16 M	1.16 M	-2.12 M	-2.12 M	-2.12 M	-2.12 M

All numbers in USD currency